These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 29545311)

  • 21. Design and synthesis of estrogen receptor degradation inducer based on a protein knockdown strategy.
    Demizu Y; Okuhira K; Motoi H; Ohno A; Shoda T; Fukuhara K; Okuda H; Naito M; Kurihara M
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1793-6. PubMed ID: 22277276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein Knockdown Technology: Application of Ubiquitin Ligase to Cancer Therapy.
    Ohoka N; Shibata N; Hattori T; Naito M
    Curr Cancer Drug Targets; 2016; 16(2):136-46. PubMed ID: 26560118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting the Allosteric Site of Oncoprotein BCR-ABL as an Alternative Strategy for Effective Target Protein Degradation.
    Shimokawa K; Shibata N; Sameshima T; Miyamoto N; Ujikawa O; Nara H; Ohoka N; Hattori T; Cho N; Naito M
    ACS Med Chem Lett; 2017 Oct; 8(10):1042-1047. PubMed ID: 29057048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peptide Stapling Improves the Sustainability of a Peptide-Based Chimeric Molecule That Induces Targeted Protein Degradation.
    Yokoo H; Ohoka N; Takyo M; Ito T; Tsuchiya K; Kurohara T; Fukuhara K; Inoue T; Naito M; Demizu Y
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel small-molecule IAP antagonist, AZD5582, draws Mcl-1 down-regulation for induction of apoptosis through targeting of cIAP1 and XIAP in human pancreatic cancer.
    Moon JH; Shin JS; Hong SW; Jung SA; Hwang IY; Kim JH; Choi EK; Ha SH; Kim JS; Kim KM; Hong DW; Kim D; Kim YS; Kim JE; Kim KP; Hong YS; Choi EK; Lee JS; Hattersley M; Jin DH; Kim TW
    Oncotarget; 2015 Sep; 6(29):26895-908. PubMed ID: 26314849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a Potent Protein Degrader against Oncogenic BCR-ABL Protein.
    Shibata N; Ohoka N; Hattori T; Naito M
    Chem Pharm Bull (Tokyo); 2019; 67(3):165-172. PubMed ID: 30827996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a peptide-based inducer of nuclear receptors degradation.
    Demizu Y; Ohoka N; Nagakubo T; Yamashita H; Misawa T; Okuhira K; Naito M; Kurihara M
    Bioorg Med Chem Lett; 2016 Jun; 26(11):2655-8. PubMed ID: 27086122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of cIAP1 and XIAP in Apoptosis Induced by Tumor Necrosis Factor Alpha in Esophageal Squamous Cell Carcinoma Cells.
    Hikami S; Shiozaki A; Kitagawa-Juge M; Ichikawa D; Kosuga T; Konishi H; Komatsu S; Fujiwara H; Okamoto K; Otsuji E
    Dig Dis Sci; 2017 Mar; 62(3):652-659. PubMed ID: 28050781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis and biological evaluation of nuclear receptor-degradation inducers.
    Itoh Y; Kitaguchi R; Ishikawa M; Naito M; Hashimoto Y
    Bioorg Med Chem; 2011 Nov; 19(22):6768-78. PubMed ID: 22014751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer cell death induced by novel small molecules degrading the TACC3 protein via the ubiquitin-proteasome pathway.
    Ohoka N; Nagai K; Hattori T; Okuhira K; Shibata N; Cho N; Naito M
    Cell Death Dis; 2014 Nov; 5(11):e1513. PubMed ID: 25375378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-based design and molecular profiling of Smac-mimetics selective for cellular IAPs.
    Corti A; Milani M; Lecis D; Seneci P; de Rosa M; Mastrangelo E; Cossu F
    FEBS J; 2018 Sep; 285(17):3286-3298. PubMed ID: 30055105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor necrosis factor-α-induced apoptosis of gastric cancer MKN28 cells: accelerated degradation of the inhibitor of apoptosis family members.
    Kitagawa M; Shiozaki A; Ichikawa D; Nakashima S; Kosuga T; Konishi H; Komatsu S; Fujiwara H; Okamoto K; Otsuji E
    Arch Biochem Biophys; 2015 Jan; 566():43-8. PubMed ID: 25513960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted Protein Degradation by Chimeric Small Molecules, PROTACs and SNIPERs.
    Naito M; Ohoka N; Shibata N; Tsukumo Y
    Front Chem; 2019; 7():849. PubMed ID: 31921772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The RING domain of cIAP1 mediates the degradation of RING-bearing inhibitor of apoptosis proteins by distinct pathways.
    Cheung HH; Plenchette S; Kern CJ; Mahoney DJ; Korneluk RG
    Mol Biol Cell; 2008 Jul; 19(7):2729-40. PubMed ID: 18434593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytoprotective effects of IAPs revealed by a small molecule antagonist.
    Galbán S; Hwang C; Rumble JM; Oetjen KA; Wright CW; Boudreault A; Durkin J; Gillard JW; Jaquith JB; Morris SJ; Duckett CS
    Biochem J; 2009 Feb; 417(3):765-71. PubMed ID: 18851715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
    Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
    Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
    [No Abstract]   [Full Text] [Related]  

  • 38. Bivalent Ligands for Protein Degradation in Drug Discovery.
    Scheepstra M; Hekking KFW; van Hijfte L; Folmer RHA
    Comput Struct Biotechnol J; 2019; 17():160-176. PubMed ID: 30788082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.
    Gougelet A; Bouclier C; Marsaud V; Maillard S; Mueller SO; Korach KS; Renoir JM
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):71-81. PubMed ID: 15862952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances in IAP-based PROTACs (SNIPERs) as potential therapeutic agents.
    Wang C; Zhang Y; Shi L; Yang S; Chang J; Zhong Y; Li Q; Xing D
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):1437-1453. PubMed ID: 35589670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.